Hoth Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for dermatological disorders, utilizing advanced drug formulation techniques to address unmet medical needs in skin health. Their focus is on improving patient quality of life through effective treatments for conditions such as eczema and psoriasis.
Funding
$2.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many dermatological disorders, such as eczema and psoriasis, lack targeted and effective therapies, leading to a reduced quality of life for patients. Current treatments often fail to address the underlying causes of these conditions or have significant side effects. This creates a need for innovative solutions that can provide relief and improve long-term outcomes.
Solution
Hoth Therapeutics is developing targeted therapies for dermatological disorders using advanced drug formulation techniques. The company focuses on creating innovative treatments that address unmet medical needs in skin health, with the goal of improving patient quality of life. Their pipeline includes therapeutics designed to target the underlying causes of conditions like eczema and psoriasis, offering the potential for more effective and long-lasting relief.
Target Audience
The primary target audience includes individuals suffering from dermatological disorders such as eczema and psoriasis, as well as healthcare professionals seeking more effective treatment options for these conditions.
Features
- Development of targeted therapies for dermatological disorders.
- Utilization of advanced drug formulation techniques.
- Focus on unmet medical needs in skin health.
- Pipeline includes treatments for eczema and psoriasis.